knowledge -WSS

knowledge

author：entertainment 2025-09-30 09:57:13 - browse：33528

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： EpiPen alternative approval delay highlights citizen petition issue

explore

WSS

Intarcia’s device

Emergency workers more likely to restrain Black patients: study

Changes to biosimilar regulatory framework must prioritize patients

Thermo Fisher plant for manufacturing gene therapies to expand

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Doctors find melanoma drugs effective against rare brain cancer

hotspot

knowledge

knowledge

Affirmative action in medical school literally saved lives

Senators: Long

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medical student insurance fails on mental health care coverage

Medical leaders decry Supreme Court decision on affirmative action

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

DIEP, the 'gold standard' of breast reconstruction, is under threat

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

George Santos makes 1st court appearance after pleading not guilty to 13 counts

How AI helped researchers track recovery from depression

entertainment

Experts study whether long Covid risk adds up with each reinfection

EHR maker NextGen Healthcare to pay $31M to resolve fraud claims

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Why are Kaiser Permanente staff considering a strike?

What Congress can do to address the rural doctor shortage

Microbiome research is starting to find links to chronic diseases

focus

explore

leisure time

Wikipedia